Surgery best way to reduce paediatric refractive error

Article

Refractive surgery in children with severe anisometropia or ametropia produces relatively stable results, according to a study published in the American Orthoptic Journal.

Refractive surgery in children with severe anisometropia or ametropia produces relatively stable results, according to a study published in the American Orthoptic Journal.

Evelyn A. Paysse, MD of the Baylor College of Medicine, Houston, US studied photorefractive keractectomy (PRK) in nine patients with paediatric anisometropic amblyopia.

Thirty-six months after surgery, seven patients displayed a two or more line improvement in uncorrected visual acuity (UCVA). Two displayed an improvement of two or more lines in best corrected visual acuity (BCVA). Refractive error stability was good, with 50% of myopic patients and 100% of hyperopic patients within 2 D of refractive target.

The researchers concluded that refractive surgery produced stable results for reducing refractive error in paediatric patients, and that UCVA and BCVA also improved subsequent to surgery in these patients.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.